Commentary
Commentary
Has the time come to bury BMI in favor of other screening measures?
While BMI is a quick and inexpensive means to assess obesity, by itself it lacks the necessary components for an accurate diagnosis.
Conference Coverage
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
Commentary
Conflicting blood pressure targets: Déjà vu all over again
Arguing about 140/90 mm Hg or 130/80 mm Hg is less important than acknowledging that we should be aggressive in screening for and treating...
Commentary
The surprising occupations with higher-than-expected ovarian cancer rates
This is how these types of studies work; they tend to raise more questions than they answer.
Commentary
‘Body size is not a choice’ and deserves legal protections
Weight-based discrimination in the United States has increased by an estimated 66% over the past decade, putting it on par with the prevalence of...
Commentary
Oral GLP-1 agonists could be game changers for obesity
I hope that future developments bring the class to an even wider demographic and perhaps reduce some of the global inequities in managing type 2...
Pearl of the Month
Thoughts on primary care in 2023
Many things have been added to the plate of primary care professionals. Patients need doctors now more than ever to give excellent, compassionate...
Latest News
MD rushes in after lightning strikes four people at White House
It was like two different parts of my brain were active at the exact same time. One said “You just ran from there, idiot. Why are you running back...
Latest News
What’s new in the new jaundice guidelines?
The neurotoxic risk factors and corresponding thresholds are important.
Commentary
Tirzepatide: Therapeutic titan or costly cure?
Positioning tirzepatide as the first injectable of choice after oral treatment escalation with metformin and an SGLT2 inhibitor may remain an...
Commentary
New DEA CME mandate affects 2 million prescribers
One should not underestimate the sweeping scope of this new federal requirement.